Author:
Cybulski Cezary,Wokołorczyk Dominika,Huzarski Tomasz,Byrski Tomasz,Gronwald Jacek,Górski Bohdan,Dębniak Tadeusz,Masojć Bartłomiej,Jakubowska Anna,van de Wetering Thierry,Narod Steven A.,Lubiński Jan
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97:10389–10394
2. Chaturvedi P, Eng WK, Zhu Y et al. (1999) Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18:4047–4054
3. CHEK2 Breast Cancer Consortium (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59
4. Oldenburg RA, Kroeze-Jansema K, Kraan J et al. (2003) The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. Cancer Res 63:8153–8157
5. Vahteristo P, Bartkova J, Eerola H et al (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432–438
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献